Frontlight ResearchEarly access
CompletedNo phase
Hypofractionated Brain Radiationcavity
Key facts
- Who runs it
- Oncology Institute of Southern Switzerland
- Where
- Switzerland6 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 56 people enrolled
- Started
- Jan 2015
- Ended
- 18 Jun 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- IGRT
- SRS
- Record updated
- 17 July 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patient underwent surgery for single brain metastasis arising from solid neoplasia (lung, breast, melanoma, kidney, colorectal), with initial histological diagnosis, or selected cases with a resected lesion and a further non-resected lesion (from 1 to 2 lesions), treatable with SRS / IGRT of the surgical cavity
- Patient ≥ 18 years
- Willngness to participate in the study, written informed consent
- Performance Status according to WHO 0-I
- Good general conditions and organ function
- Newly diagnosed chemotherapy-naïve disease or controlled systemic disease
- Good bone marrow, renal and hepatic function
- Stable steroid dose or reduced for at least 5 days
Who cannot take part
- History of previous brain irradiation
- Histological diagnosis other than lung, breast, melanoma, kidney and colorectal malignancy
- Pregnancy or breastfeeding
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Stereotactic radiosurgery or hypofractionated radiotherapy of the resection cavity after metastasectomy in cancer patients with brain metastases
The 2 groups in the trial
- IGRTTreatment being tested
Image-Guided Hypofractionated Stereotactic Radiation Therapy (IGRT) of the resection cavity
- SRSTreatment being tested
Stereotactic Radiosurgery of the resection cavity (SRS)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Stereotactic Radiosurgery or Hypofractionated Image-Guided Radiotherapy to the Surgical Cavity After Resection of Brain Metastases: a Multicenter, Single Arm, Open-label, Phase II Trial
- Record updated
- 17 July 2024